HUANG, DAVID,STEINMANN, GERHARD GUSTAV,STERN, JERRY O
申请号：
NZ59103009
公开号：
NZ591030A
申请日:
2009.09.14
申请国别(地区):
NZ
年份:
2012
代理人:
摘要：
Disclosed is the use of a combination of: a compound of formula (1), interferon alpha, and ribavirin for the manufacture of a medicament for the treatment of hepatitis C virus (HCV) infection or alleviating one or more symptoms thereof. The compound of formula (1) is a selective and potent inhibitor of the HCV NS3 serine protease, and comprised quinoline, thiophene and cyclopropane moieties.
